Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes
- PMID: 24359475
- PMCID: PMC3936468
- DOI: 10.1111/ahg.12044
Genetic variation in the peroxisome proliferator-activated receptor (PPAR) and peroxisome proliferator-activated receptor gamma co-activator 1 (PGC1) gene families and type 2 diabetes
Abstract
We used a two-stage study design to evaluate whether variations in the peroxisome proliferator-activated receptors (PPAR) and the PPAR gamma co-activator 1 (PGC1) gene families (PPARA, PPARG, PPARD, PPARGC1A, and PPARGC1B) are associated with type 2 diabetes (T2D) risk. Stage I used data from a genome-wide association study (GWAS) from Shanghai, China (1019 T2D cases and 1709 controls) and from a meta-analysis of data from the Asian Genetic Epidemiology Network for T2D (AGEN-T2D). Criteria for selection of single nucleotide polymorphisms (SNPs) for stage II were: (1) P < 0.05 in single marker analysis in Shanghai GWAS and P < 0.05 in the meta-analysis or (2) P < 10(-3) in the meta-analysis alone and (3) minor allele frequency ≥ 0.10. Nine SNPs from the PGC1 family were assessed in stage II (an independent set of middle-aged men and women from Shanghai with 1700 T2D cases and 1647 controls). One SNP in PPARGC1B, rs251464, was replicated in stage II (OR = 0.87; 95% CI: 0.77-0.99). Gene-body mass index (BMI) and gene-exercise interactions and T2D risk were evaluated in a combined dataset (Shanghai GWAS and stage II data: 2719 cases and 3356 controls). One SNP in PPARGC1A, rs12640088, had a significant interaction with BMI. No interactions between the PPARGC1B gene and BMI or exercise were observed.
Keywords: PGC1; PPAR; Type 2 diabetes.
© 2013 John Wiley & Sons Ltd/University College London.
References
-
- Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res. Clin. Pract. 2005;67(2):175–179. available from: PM:15649578. - PubMed
-
- Andersen G, Wegner L, Yanagisawa K, Rose CS, Lin J, Glumer C, Drivsholm T, Borch-Johnsen K, Jorgensen T, Hansen T, Spiegelman BM, Pedersen O. Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J. Med. Genet. 2005;42(5):402–407. available from: PM:15863669. - PMC - PubMed
-
- Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes. 2006;55(7):2148–2152. available from: PM:16804087. - PubMed
-
- Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'Rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia. 2006;49(3):501–505. available from: PM:16435105. - PubMed
-
- Cai H, Zheng W, Xiang YB, Xu WH, Yang G, Li H, Shu XO. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br. J. Nutr. 2007;98(5):1006–1013. available from: PM:17524168. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 1 UL1 RR024975/RR/NCRR NIH HHS/United States
- R01 DK058845/DK/NIDDK NIH HHS/United States
- R01 CA122756/CA/NCI NIH HHS/United States
- R01CA64277/CA/NCI NIH HHS/United States
- R01 CA092585/CA/NCI NIH HHS/United States
- K01 DK082639/DK/NIDDK NIH HHS/United States
- R01CA118229/CA/NCI NIH HHS/United States
- KO1DK082639/DK/NIDDK NIH HHS/United States
- P30 CA068485/CA/NCI NIH HHS/United States
- R01CA124558/CA/NCI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- U01 HG004399/HG/NHGRI NIH HHS/United States
- R01CA122756/CA/NCI NIH HHS/United States
- R01CA92585/CA/NCI NIH HHS/United States
- P30 CA68485/CA/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- DK58845/DK/NIDDK NIH HHS/United States
- HG004399/HG/NHGRI NIH HHS/United States
- R01 CA090899/CA/NCI NIH HHS/United States
- R01 CA100374/CA/NCI NIH HHS/United States
- R01CA100374/CA/NCI NIH HHS/United States
- R01 CA064277/CA/NCI NIH HHS/United States
- R37CA70867/CA/NCI NIH HHS/United States
- R01 CA118229/CA/NCI NIH HHS/United States
- R01 CA124558/CA/NCI NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- R01CA90899/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
